Clinical Trial Update: Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rasagiline in advanced Parkinson's disease patients with motor fluctuations receiving levodopa/carbidopa; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED